Quality of Life and Patient Satisfaction at 7-Year Follow-up of Antibiotic Therapy vs Appendectomy for Uncomplicated Acute Appendicitis: A Secondary Analysis of a Randomized Clinical Trial.


Journal

JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553

Informations de publication

Date de publication:
01 04 2020
Historique:
pubmed: 20 2 2020
medline: 18 11 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

Long-term results support antibiotics for uncomplicated acute appendicitis as an alternative to appendectomy. To our knowledge, treatment-related long-term patient satisfaction and quality of life (QOL) are not known. To determine patient satisfaction and QOL after antibiotic therapy and appendectomy for treating uncomplicated acute appendicitis. Open appendectomy vs antibiotics with intravenous ertapenem, 1 g once daily, for 3 days followed by 7 days of oral levofloxacin, 500 mg once daily, and metronidazole, 500 mg 3 times per day. This observational follow-up of the Appendicitis Acuta (APPAC) multicenter randomized clinical trial comparing appendectomy with antibiotics included 530 patients age 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis who were randomized to undergo appendectomy (273 [52%]) or receive antibiotics (257 [49%]). The trial was conducted from November 2009 to June 2012; the last follow-up was May 9, 2018. The data were analyzed in February 2019. In this analysis, post hoc secondary end points of postintervention QOL (EQ-5D-5L) and patient satisfaction and treatment preference were evaluated. Of the 530 patients enrolled in the trial (appendectomy group: 273 [174 men (64%)] with a median age of 35 years; (antibiotic group: 257 [155 men (60%)] with a median age of 33 years), 423 patients (80%) were available for phone interview at a median follow-up of 7 years; 206 patients (80%) took antibiotics and 217 (79%) underwent appendectomy. Of the 206 patients taking antibiotics, 81 (39%) had undergone appendectomy. The QOL between appendectomy and antibiotic group patients was similar (median health index value, 1.0 in both groups; 95% CI, 0.86-1.0; P = .96). Patients who underwent appendectomy were more satisfied in the treatment than patients taking antibiotics (68% very satisfied, 21% satisfied, 6% indifferent, 4% unsatisfied, and 1% very unsatisfied in the appendectomy group and 53% very satisfied, 21% satisfied, 13% indifferent, 7% unsatisfied, and 6% very unsatisfied in the antibiotic group; P < .001) and in a subgroup analysis this difference was based on the antibiotic group patients undergoing appendectomy. There was no difference in patient satisfaction after successful antibiotic treatment compared with appendectomy (cumulative odds ratio [COR], 7.8; 95% CI, 0.5-1.3; P < .36). Patients with appendectomy or with successful antibiotic therapy were more satisfied than antibiotic group patients who later underwent appendectomy (COR, 7.7; 95% CI, 4.6-12.9; P < .001; COR, 9.7; 95% CI, 5.4-15.3; P < .001, respectively). Of the 81 patients taking antibiotics who underwent appendectomy, 27 (33%) would again choose antibiotics as their primary treatment. In this analysis, long-term QOL was similar after appendectomy and antibiotic therapy for the treatment of uncomplicated acute appendicitis. Patients taking antibiotics who later underwent appendectomy were less satisfied than patients with successful antibiotics or appendectomy. Clinicaltrials.gov Identifier: NCT01022567.

Identifiants

pubmed: 32074268
pii: 2761312
doi: 10.1001/jamasurg.2019.6028
pmc: PMC7042917
doi:

Substances chimiques

Anti-Bacterial Agents 0

Banques de données

ClinicalTrials.gov
['NCT01022567']

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-289

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

BMC Surg. 2013 Feb 08;13:3
pubmed: 23394263
World J Surg. 2006 Jun;30(6):1033-7
pubmed: 16736333
Surg Infect (Larchmt). 2017 Nov/Dec;18(8):868-873
pubmed: 29027898
Br J Surg. 2014 Jan;101(1):e9-22
pubmed: 24272924
Br J Surg. 2017 Sep;104(10):1355-1361
pubmed: 28677879
Ann Surg. 2017 May;265(5):889-900
pubmed: 27759621
BMC Surg. 2018 Dec 17;18(1):117
pubmed: 30558607
JAMA Surg. 2016 May 1;151(5):408-15
pubmed: 26676711
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Ir J Med Sci. 2018 Nov;187(4):1029-1038
pubmed: 29423825
Br J Surg. 2016 May;103(6):656-667
pubmed: 26990957
J Trauma Acute Care Surg. 2019 Apr;86(4):722-736
pubmed: 30516592
J Am Coll Surg. 2014 Aug;219(2):272-9
pubmed: 24951281
Ann Surg. 2015 Jan;261(1):67-71
pubmed: 25072441
JAMA. 2018 Sep 25;320(12):1259-1265
pubmed: 30264120
Br J Surg. 2009 May;96(5):473-81
pubmed: 19358184
Int J Surg. 2014;12(8):848-57
pubmed: 25019228
Lancet. 2011 May 7;377(9777):1573-9
pubmed: 21550483
Eur J Health Econ. 2013 Jul;14 Suppl 1:S1-3
pubmed: 23900659
J Am Coll Surg. 2016 Mar;222(3):309-14
pubmed: 26712246
Cochrane Database Syst Rev. 2018 Nov 28;11:CD001546
pubmed: 30484855
Am J Surg. 2019 Jul;218(1):192-200
pubmed: 30340760
Br J Surg. 2017 Dec;104(13):1785-1790
pubmed: 28925502
World J Emerg Surg. 2016 Jul 18;11:34
pubmed: 27437029
Arch Surg. 2011 Mar;146(3):308-14
pubmed: 21422362
JAMA Surg. 2018 May 1;153(5):471-478
pubmed: 29322168
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
JAMA Surg. 2016 Feb;151(2):107-8
pubmed: 26579853
BMJ Open. 2018 Nov 3;8(11):e023623
pubmed: 30391919
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
JAMA. 2015 Jun 16;313(23):2340-8
pubmed: 26080338
Health Policy. 2019 Feb;123(2):159-165
pubmed: 30598239
JAMA. 2018 Sep 25;320(12):1245-1246
pubmed: 30264100

Auteurs

Suvi Sippola (S)

Turku University Hospital, Division of Digestive Surgery and Urology, University of Turku, Turku, Finland.
Department of Surgery, University of Turku, Turku, Finland.

Jussi Haijanen (J)

Turku University Hospital, Division of Digestive Surgery and Urology, University of Turku, Turku, Finland.
Department of Surgery, University of Turku, Turku, Finland.

Lauri Viinikainen (L)

Department of Surgery, University of Turku, Turku, Finland.

Juha Grönroos (J)

Turku University Hospital, Division of Digestive Surgery and Urology, University of Turku, Turku, Finland.
Department of Surgery, University of Turku, Turku, Finland.

Hannu Paajanen (H)

Department of Surgery, Mikkeli Central Hospital, Mikkeli, Finland.

Tero Rautio (T)

Department of Surgery, Oulu University Hospital, Oulu, Finland.

Pia Nordström (P)

Division of Surgery, Gastroenterology and Oncology, Tampere University Hospital, Tampere, Finland.

Markku Aarnio (M)

Department of Surgery, Jyväskylä Central Hospital, Jyväskylä, Finland.

Tuomo Rantanen (T)

Department of Surgery, Kuopio University Hospital, Kuopio, Finland.
Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland.

Saija Hurme (S)

Department of Biostatistics, University of Turku, Turku, Finland.

Jukka-Pekka Mecklin (JP)

Department of Surgery, Jyväskylä Central Hospital, Jyväskylä, Finland.
Department of Sport and Health Sciences, Jyväskylä University, Jyväskylä, Finland.

Juhani Sand (J)

Department of Health and Medical Services, Päijät-Häme Joint Authority for Health and Wellbeing, Lahti, Finland.

Airi Jartti (A)

Department of Radiology, Oulu University Hospital, Oulu, Finland.

Paulina Salminen (P)

Turku University Hospital, Division of Digestive Surgery and Urology, University of Turku, Turku, Finland.
Department of Surgery, University of Turku, Turku, Finland.
Satakunta Central Hospital, Pori, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH